R&G PharmaStudies Co (SZSE:301333) Net Margin % : 13.00% (As of Mar. 2024)

R&G PharmaStudies Co Net Margin % Chart

R&G PharmaStudies Co Annual Data
	Trend	Dec13	Dec14	Dec15	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Net Margin %		Get a 7-Day Free Trial					19.42	17.31	16.31	17.79	22.53

R&G PharmaStudies Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Margin %	Get a 7-Day Free Trial															17.89	28.45	24.51	18.64	13.00

Competitive Comparison of R&G PharmaStudies Co's Net Margin %

For the Biotechnology subindustry, R&G PharmaStudies Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

R&G PharmaStudies Co's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, R&G PharmaStudies Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where R&G PharmaStudies Co's Net Margin % falls into.

R&G PharmaStudies Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

R&G PharmaStudies Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

R&G PharmaStudies Co's Net Margin for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

R&G PharmaStudies Co  (SZSE:301333) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

R&G PharmaStudies Co Net Margin % Related Terms

Thank you for viewing the detailed overview of R&G PharmaStudies Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

R&G PharmaStudies Co (SZSE:301333) Business Description